Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study

American Journal of Epidemiology

Volumn 171, Issue 10, 2010, Pages 1144-1152

  Wang, George C ^a   Kao, Wen Hong L ^b   Murakami, Peter ^b   Xue, Qian Li ^a   Chiou, Roger B ^a   Detrick, Barbara ^a   McDyer, John F ^a   Semba, Richard D ^a   Casolaro, Vincenzo ^a   Walston, Jeremy D ^a   Fried, Linda P ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

Antibodies; Cytomegalovirus; Frail elderly; Immunoglobulin G; Inflammation; Interleukin 6; Mortality; Viral; Virus latency

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

AGING; ANTIBODY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE PREVALENCE; ELDERLY POPULATION; HEALTH IMPACT; HEALTH RISK; HEALTH SURVEY; IMMUNOCOMPETENCE; MORTALITY; PROTEIN; SERUM; VIRAL DISEASE; WOMENS HEALTH;

AGED; AGING; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GERIATRICS; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; SENESCENCE; SEROLOGY; UNITED STATES; WOMEN'S HEALTH;

AGE FACTORS; AGED; ANTIBODIES, VIRAL; BALTIMORE; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FRAIL ELDERLY; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

BALTIMORE; MARYLAND; UNITED STATES;

CYTOMEGALOVIRUS;

EID: 77952409018     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq062     Document Type: Article

References (39)

1. Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2008;197(2):65-73.
2. Reeves MB, MacAry PA, Lehner PJ, et al. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA. 2005;102(11):4140-4145.
3. Bentz GL, Jarquin-Pardo M, Chan G, et al. Human cytomeg-alovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol. 2006;80(23):11539-11555.
4. Mocarski ES Jr, Shenk T, Pass RF. Cytomegaloviruses. In: Knipe DM, Howley PM, Griffin DE, et al, eds. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
5. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006;43(9):1143-1151.
6. Sorlie PD, Nieto FJ, Adam E, et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2000;160(13):2027-2032.
7. Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2(8554):291-293.
8. Blum A, Giladi M, Weinberg M, et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998;81(7):866-868.
9. Aiello AE, Haan MN, Pierce CM, et al. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci. 2008;63(6):610-618.
10. Aiello AE, Haan M, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54(7):1046-1054. (Pubitemid 43992540)
11. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300(4):413-422.
12. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalo-virus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005;53(5):747-754.
13. Strandberg TE, Pitkälä KH. Frailty in elderly people. Lancet. 2007;369(9570):1328-1329.
14. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.
15. Adler SP, Hur JK, Wang JB, et al. Prior infection with cyto-megalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998;177(1):209-212.
16. Strandberg TE, Pitkala KH, Tilvis RS. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA. 2009;301(4): 380-382.
17. Mehta SK, Stowe RP, Feiveson AH, et al. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis. 2000;182(6):1761-1764.
18. McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis. 1989;160(1): 1-10.
19. Fried LP, Kasper JD, Guralnik JM, et al. The Women's Health and Aging Study: an introduction. In: Guralnik JM, Fried LP, Simonsick EM, et al, eds. The Women' s Health and Aging Study: Health and Social Characteristics of Older Women With Disability. Bethesda, MD: National Institute on Aging; 1995:1-8. (NIH publication 95-4009).
20. Fried LP, Bandeen-Roche K, Chaves PH, et al. Preclinical mobility disability predicts incident mobility disability in older women. J Gerontol A Biol Sci Med Sci. 2000;55(1): M43-M52.
21. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the Women's Health and Aging Studies. J Gerontol A Biol Sci Med Sci. 2006;61(3): 262-266.
22. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239-241.
23. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994; 81(3):515-526.
24. Chu A, Maffeo CE, Lo A, et al. Sample design, weighting and estimation procedures, and computation of sampling errors. In: Guralnik JM, Fried LP, Simonsick EM, et al, eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women With Disability. Bethesda, MD: National Institute on Aging; 1995:A1-A13. NIH publication 95-4009.
25. Newman AB, Gottdiener JS, Mcburnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56(3):M158-M166.
26. Woods NF, LaCroix AZ, Gray SL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53(8):1321-1330.
27. Hubbard RE, Searle SD, Mitnitski A, et al. Effect of smoking on the accumulation of deficits, frailty and survival in older adults: a secondary analysis from the Canadian Study of Health and Aging. J Nutr Health Aging. 2009;13(5):468-472.
28. Mocarski ES Jr. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 2002;10(7):332-339.
29. Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42(6): 563-570.
30. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350(9075): 430-436.
31. Penfold ME, Dairaghi DJ, Duke GM, et al. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA. 1999;96(17):9839-9844.
32. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3): 255-263.
33. Blankenberg S, Rupprecht HJ, Bickel C, et al. Cytomegalo-virus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation. 2001;103(24):2915-2921.
34. Geist LJ, Dai LY. Cytomegalovirus modulates interleukin-6 gene expression. Transplantation. 1996;62(5):653-658.
35. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245-270.
36. Prösch S, Heine AK, Volk HD, et al. CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem. 2001;276(44):40712- 40720.
37. Zhu J, Shearer GM, Marincola FM, et al. Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. Int Immunol. 2001;13(6):785-790.
38. Tosswill JH, Ridley DS. The cryopreservation of standard sera. J Clin Pathol. 1981;34(1):76-77.
39. Zhu J, Shearer GM, Norman JE, et al. Host response to cyto-megalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation. 2000;102(20): 2491-2496.